709.59 USD
-4.95
0.69%
At close Jul 11, 4:00 PM EDT
After hours
709.59
+0.00
0.00%
1 day
-0.69%
5 days
-1.45%
1 month
-1.14%
3 months
2.93%
6 months
21.28%
Year to date
25.32%
1 year
23.36%
5 years
389.44%
10 years
206.61%
 

About: McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Employees: 51,000

0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 109

44% more funds holding in top 10

Funds holding in top 10: 36 [Q4 2024] → 52 (+16) [Q1 2025]

14% more capital invested

Capital invested by funds: $63.4B [Q4 2024] → $72.5B (+$9.1B) [Q1 2025]

5% more funds holding

Funds holding: 1,641 [Q4 2024] → 1,716 (+75) [Q1 2025]

0.17% more ownership

Funds ownership: 85.83% [Q4 2024] → 86.0% (+0.17%) [Q1 2025]

4% less repeat investments, than reductions

Existing positions increased: 594 | Existing positions reduced: 616

5% less call options, than puts

Call options by funds: $616M | Put options by funds: $648M

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$766
8%
upside
Avg. target
$788
11%
upside
High target
$805
13%
upside

5 analyst ratings

positive
80%
neutral
20%
negative
0%
Evercore ISI Group
Elizabeth Anderson
13%upside
$800
Outperform
Maintained
9 Jul 2025
Morgan Stanley
Erin Wright
9%upside
$770
Overweight
Maintained
11 Jun 2025
Wells Fargo
Stephen Baxter
8%upside
$766
Equal-Weight
Maintained
3 Jun 2025
B of A Securities
Michael Cherny
13%upside
$800
Buy
Maintained
9 May 2025
UBS
Kevin Caliendo
13%upside
$805
Buy
Maintained
29 Apr 2025

Financial journalist opinion

Based on 21 articles about MCK published over the past 30 days

Positive
Zacks Investment Research
1 day ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Positive
Zacks Investment Research
2 days ago
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Neutral
Zacks Investment Research
3 days ago
Why McKesson (MCK) Dipped More Than Broader Market Today
McKesson (MCK) concluded the recent trading session at $724.11, signifying a -1.53% move from its prior day's close.
Why McKesson (MCK) Dipped More Than Broader Market Today
Positive
Zacks Investment Research
1 week ago
Why McKesson (MCK) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
1 week ago
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Positive
Zacks Investment Research
1 week ago
Here's Why McKesson (MCK) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why McKesson (MCK) is a Strong Growth Stock
Negative
Zacks Investment Research
1 week ago
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know
McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day.
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know
Positive
Zacks Investment Research
1 week ago
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
These women-run company stocks offer high growth and stability.
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
Positive
Zacks Investment Research
1 week ago
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Positive
Zacks Investment Research
1 week ago
5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
AEM, NTES, QFIN, UGI and MCK stand out as strong dividend growth picks for steady income and upside in 2H25.
5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
Charts implemented using Lightweight Charts™